Human immune repertoire in hepatitis B virus infection

被引:0
|
作者
Qiao Zhan [1 ]
Jing-Hang Xu [1 ]
Yan-Yan Yu [1 ]
Emily Lo KK [2 ]
Felicianna [2 ]
Hani El-Nezami [2 ,3 ]
Zheng Zeng [1 ]
机构
[1] Department of Infectious Diseases, Peking University First Hospital
[2] School of Biological Sciences, University of Hong Kong
[3] Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland
基金
中国国家自然科学基金;
关键词
Immune repertoire; T-cell receptor; B-cell receptor; Hepatitis B virus; Chronic viral infection; High-throughput sequencing;
D O I
暂无
中图分类号
R512.62 [];
学科分类号
100401 ;
摘要
Hepatitis B virus(HBV) infection is a public health threat that affects 257 million people worldwide and can progress to liver cirrhosis, liver failure, and hepatocellular carcinoma. The HBV antigen-induced adaptive immune response plays an important role in HBV clearance. Immune repertoire sequencing(IRS) has been used to investigate the molecular mechanisms behind the immune system, find novel ways to treat HBV infection, and evaluate the genetic responses and immune characteristics of individuals infected by HBV or immunized by HBV vaccine. This review summarizes the human immune repertoire analysis methodology, and the application of the IRS in the prediction of HBV infection progression, treatment, and vaccination.
引用
收藏
页码:3790 / 3801
页数:12
相关论文
共 50 条
  • [21] Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism
    Yue, YF
    Yang, XJ
    Zhang, SL
    CHINESE MEDICAL JOURNAL, 1999, 112 (01) : 37 - 39
  • [22] Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin:efficacy and mechanism
    岳亚飞
    杨晓菊
    张树林
    中华医学杂志(英文版), 1999, (01) : 38 - 40
  • [23] Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin:efficacy and mechanism
    岳亚飞
    杨晓菊
    张树林
    Chinese Medical Journal, 1999, (01)
  • [24] Autoimmune hepatitis in the course of human immune deficiency virus infection
    Stefaniuk, Piotr
    Dusza, Marta
    Wiercinska-Drapalo, Alicja
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (01): : 1 - 7
  • [25] Human genetic susceptibility to hepatitis B virus infection
    Xu, Jinghang
    Zhan, Qiao
    Fan, Yanan
    Yu, Yanyan
    Zeng, Zheng
    INFECTION GENETICS AND EVOLUTION, 2021, 87
  • [26] Human genes involved in hepatitis B virus infection
    Zeng, Zheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (24) : 7696 - 7706
  • [27] Human genes involved in hepatitis B virus infection
    Zheng Zeng
    World Journal of Gastroenterology, 2014, (24) : 7696 - 7706
  • [28] Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins
    Safadi, R
    Israeli, E
    Papo, O
    Shibolet, O
    Melhem, A
    Bloch, A
    Rowe, M
    Alper, R
    Klein, A
    Hemed, N
    Segol, O
    Thalenfeld, B
    Engelhardt, D
    Rabbani, E
    Ilan, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (11): : 2505 - 2515
  • [29] The study of immune checkpoint inhibitors in chronic hepatitis B virus infection
    Li, Siyu
    Li, Na
    Yang, Shanru
    Deng, Haiyan
    Li, Yanguo
    Wang, Yixuan
    Yang, Jiaqiang
    Lv, Jiaxin
    Dong, Lan
    Yu, Guansen
    Hou, Xin
    Wang, Geng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109
  • [30] Effect of immune checkpoint inhibitors on patients with hepatitis B virus infection
    Mon, Hsien-Chen
    Lee, Pei-Chang
    Chi, Chen-Ta
    Huang, Yi-Hsiang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2025, 88 (02) : 93 - 97